First Header Logo Second Header Logo

Connection

Michael Nader to Disease Models, Animal

This is a "connection" page, showing publications Michael Nader has written about Disease Models, Animal.
Connection Strength

1.540
  1. Nader MA. Animal models for addiction medicine: From vulnerable phenotypes to addicted individuals. Prog Brain Res. 2016; 224:3-24.
    View in: PubMed
    Score: 0.395
  2. Nader MA, Czoty PW. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am J Psychiatry. 2005 Aug; 162(8):1473-82.
    View in: PubMed
    Score: 0.194
  3. Porrino LJ, Beveridge TJ, Smith HR, Nader MA. Functional consequences of cocaine expectation: findings in a non-human primate model of cocaine self-administration. Addict Biol. 2016 May; 21(3):519-29.
    View in: PubMed
    Score: 0.094
  4. Nader MA, Balster RL, Henningfield JE. William L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants. Neuropharmacology. 2014 Dec; 87:4-8.
    View in: PubMed
    Score: 0.089
  5. Phillips KA, Bales KL, Capitanio JP, Conley A, Czoty PW, 't Hart BA, Hopkins WD, Hu SL, Miller LA, Nader MA, Nathanielsz PW, Rogers J, Shively CA, Voytko ML. Why primate models matter. Am J Primatol. 2014 Sep; 76(9):801-27.
    View in: PubMed
    Score: 0.089
  6. Nader MA, Banks ML. Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging. Neuropharmacology. 2014 Jan; 76 Pt B:510-7.
    View in: PubMed
    Score: 0.084
  7. Gould RW, Duke AN, Nader MA. PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations. Neuropharmacology. 2014 Sep; 84:138-51.
    View in: PubMed
    Score: 0.082
  8. Nader MA, Czoty PW, Nader SH, Morgan D. Nonhuman primate models of social behavior and cocaine abuse. Psychopharmacology (Berl). 2012 Nov; 224(1):57-67.
    View in: PubMed
    Score: 0.079
  9. Gould RW, Porrino LJ, Nader MA. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation. Curr Top Behav Neurosci. 2012; 11:25-44.
    View in: PubMed
    Score: 0.076
  10. Blaylock BL, Nader MA. Dopamine D3 receptor function and cocaine exposure. Neuropsychopharmacology. 2012 Jan; 37(1):297-8.
    View in: PubMed
    Score: 0.076
  11. Czoty PW, Gould RW, Martelle JL, Nader MA. Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys. Neuropsychopharmacology. 2011 Jan; 36(2):539-47.
    View in: PubMed
    Score: 0.070
  12. Czoty PW, Gage HD, Nader MA. Differences in D2 dopamine receptor availability and reaction to novelty in socially housed male monkeys during abstinence from cocaine. Psychopharmacology (Berl). 2010 Mar; 208(4):585-92.
    View in: PubMed
    Score: 0.067
  13. Nader MA, Czoty PW. Brain imaging in nonhuman primates: insights into drug addiction. ILAR J. 2008; 49(1):89-102.
    View in: PubMed
    Score: 0.057
  14. Czoty PW, Reboussin BA, Calhoun TL, Nader SH, Nader MA. Long-term cocaine self-administration under fixed-ratio and second-order schedules in monkeys. Psychopharmacology (Berl). 2007 Apr; 191(2):287-95.
    View in: PubMed
    Score: 0.054
  15. Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol. 2012 Oct 01; 84(7):882-90.
    View in: PubMed
    Score: 0.020
  16. Porrino LJ, Smith HR, Nader MA, Beveridge TJ. The effects of cocaine: a shifting target over the course of addiction. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15; 31(8):1593-600.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.